MEDP: Q2 2026 revenue grew 17.2% year-over-year, with strong net income and robust business awards
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw revenue rise 17.2% year-over-year to $707.3 million, with net income up to $121.4 million and EBITDA margin steady at 21.7%. Full-year 2026 guidance projects up to 14% revenue growth and EPS between $17.25 and $17.95.Original document: Medpace Holdings, Inc. [MEDP] SEC 8-K Current Report — Jul. 23 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw revenue rise 17.2% year-over-year to $707.3 million, with net income up to $121.4 million and EBITDA margin steady at 21.7%. Full-year 2026 guidance projects up to 14% revenue growth and EPS between $17.25 and $17.95.
Original document: Medpace Holdings, Inc. [MEDP] SEC 8-K Current Report — Jul. 23 2026